TALKMED

The current price of 5G3 is 0.410 SGD — it has decreased by 2.38% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on SGX exchange TALKMED stocks are traded under the ticker 5G3.

TALKMED is going to release the next earnings report on Jul 30, 2024. Keep track of upcoming events with our Earnings Calendar.

5G3 stock is 2.44% volatile and has beta coefficient of 0.50. Check out the list of the most volatile stocks — is TALKMED there?

Yes, you can track TALKMED financials in yearly and quarterly reports right on TradingView.

5G3 stock has fallen by 3.53% compared to the previous week, the month change is a 12.33% rise, over the last year TALKMED has showed a 3.53% decrease.

Today TALKMED has the market capitalization of ‪557.20 M‬, it has increased by 18.42% over the last week.

TALKMED dividend yield was 5.79% in 2023, and payout ratio reached 90.53%. The year before the numbers were 7.50% and 129.87% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.

Like other stocks, 5G3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TALKMED stock right from TradingView charts — choose your broker and connect to your account.

5G3 reached its all-time high on Apr 28, 2017 with the price of 0.950 SGD, and its all-time low was 0.310 SGD and was reached on Jan 30, 2014.
See other stocks reaching their highest and lowest prices.

As of Apr 20, 2024, the company has 268.00 employees. See our rating of the largest employees — is TALKMED on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TALKMED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TALKMED stock shows the buy signal. See more of TALKMED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TALKMED EBITDA is ‪41.61 M‬ SGD, and current EBITDA margin is 49.66%. See more stats in TALKMED financial statements.